SCHEMBL6408420

SCHEMBL6408420

COc1ccccc1-n1c(SCCCCc2ccccc2)nnc1-c1ccco1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.62
NPC1 O15118 2/20 0.62
HPGD P15428 2/20 0.59
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
GAA P10253 2/20 0.51
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
TSHR P16473 7/20 0.47
MAPT P10636 1/20 0.47
MAPK1 P28482 1/20 0.47
ALOX15 P16050 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
POLB P06746 2/20 0.46
LMNA P02545 2/20 0.45
KDM4E B2RXH2 1/20 0.45
USP2 O75604 1/20 0.45
RECQL P46063 1/20 0.45
PKM P14618 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6408452 0.86 TSHR (0.62) GAATSHRMAPTLMNA
SCHEMBL6402376 0.85 TSHR (0.50) ALDH1A1KMT2ATSHRL3MBTL1
SCHEMBL6404682 0.85 DRD3 (0.50) ALDH1A1NPC1HPGDSMN1; SMN2TSHR
SCHEMBL6403506 0.83 L3MBTL1 (0.60) ALDH1A1NPC1GAASMN1; SMN2TSHR
SCHEMBL6407795 0.83 TSHR (0.48) ALDH1A1TSHRL3MBTL1
SCHEMBL6409759 0.83 TSHR (0.56) ALDH1A1HPGDGAATSHRMAPT
SCHEMBL6405379 0.82 TSHR (0.63) GAATSHRMAPTLMNA
SCHEMBL6408474 0.82 TSHR (0.55) ALDH1A1HPGDGAATSHRMAPT
SCHEMBL6403375 0.81 TSHR (0.47) NPC1HPGDMEN1KMT2AGAA
SCHEMBL6411005 0.81 TSHR (0.54) TSHRMAPK1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885NPC1 2070/4885HPGD 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.